Sensitization of Coronary α -Adrenoceptor Vasoconstriction in the Prediabetic Metabolic Syndrome

Authors: Deniz Dincer, Ü.; Araiza, Alberto; Knudson, Jarrod; Molina, Patricia; Tune, Johnathan

Source: Microcirculation, Volume 13, Number 7, October-November 2006 , pp. 587-595(9)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $42.29 plus tax (Refund Policy)

Abstract:

Objective: This study tested whether α -adrenoceptor-mediated coronary vasoconstriction is augmented in the metabolic syndrome and is accompanied by the alteration of specific α 1 - and α 2 -coronary adrenoceptors. Methods: Studies were conducted in control and chronically high-fat-fed (6 weeks of 60% calories from fat) dogs with metabolic syndrome. Alterations in coronary α 1B -, α 1D -, and α 2A -adrenoceptor mRNA and protein expression were examined by real-time PCR and Western analyses, respectively. Coronary blood flow and its response to intracoronary infusion of either the α 1 -adrenoceptor agonist methoxamine (0.1-3 mg) or the α 2 -adrenoceptor agonist BHT-933 (0.1-3 mg) were measured in anesthetized dogs. Results: Basal plasma epinephrine and norepinephrine levels were higher in the high-fat-fed dogs compared to controls. Real-time PCR revealed no alterations of coronary artery or arteriole α 1B -, α 1D -, and α 2A -adrenoceptor mRNA expression. However, Western blot analysis showed a significant decrease in α 2A -adrenoceptor protein density with no change in α 1B - or α 1D -adrenoceptors. Methoxamine and BHT-933 produced dose-dependent decreases in coronary blood flow, but the decrease in coronary flow to methoxamine was significantly greater (∼ 20%) in dogs with the metabolic syndrome. No differences in the coronary flow response to BHT-933 were noted. Conclusions: These results indicate that the metabolic syndrome is associated with sensitization of α 1 - and α 2 -adrenoceptor signaling that could significantly limit control of coronary blood flow when the sympathetic nervous system is activated.

Keywords: α-adrenoceptor; coronary blood flow; obesity

Document Type: Research article

DOI: http://dx.doi.org/10.1080/10739680600885228

Affiliations: 1: Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA

Publication date: 2006-10-01

More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page